第15回DIA日本年会

The human body is colonized by a vast number of microbes, collectively referred to as the human microbiota. Each person’s microbiome is unique, and it impacts health and diseases, such as obesity, inflammatory bowel disease (IBD), diabetes mellitus, metabolic syndrome, atherosclerosis, alcoholic liver disease (ALD), colon cancer, and autoimmune disease. Metagenomic whole genome shotgun sequencing provided insights into the functions and pathways present in the human microbiome, and microbiome-derived biomarkers, drug targets, and bioactive molecules as potential treatments and companion diagnostics have been developed. In this session, the perspective on microbiome research and utilization will be discussed.